UK News Daily NICE Approves Myeloma Treatment, King Charles Celebrates Young Talent, NHS Rolls Out Mounjaro Drug, Ballymena Protests Turn Violent, and more...
Jun 13, 2025
A revolutionary myeloma treatment, likened to a 'Trojan Horse', promises to triple survival rates. Meanwhile, King Charles III highlights young talent at a star-studded awards ceremony, with Beckham receiving a knighthood amid family drama. On the health front, the NHS prepares to roll out the Mounjaro weight loss drug, aiming to benefit 220,000 patients. However, unrest in Ballymena escalates into violent protests, raising safety concerns and highlighting urgent calls for NHS reform to improve outpatient care.
AI Snips
Chapters
Transcript
Episode notes
Revolutionary Myeloma Treatment
- Belantamab mafodotin triples progression-free survival in myeloma patients compared to current treatments.
- It delivers chemotherapy directly to cancer cells, reducing systemic side effects.
Patient's Remission Story
- Paul Sylvester achieved remission weeks after starting belantamab mafodotin treatment.
- His quality of life improved significantly post-treatment.
NHS Expands Weight Loss Drug Access
- NHS will allow GPs to prescribe the weight loss drug Mounjaro (tirzepatide) starting this month.
- This move aims to benefit 220,000 people in three years, addressing obesity's high NHS costs.